Multiple Sclerosis Fast Facts

Nov 23, 2020 | health and medicine, Karger Publishers

In Collaboration With

Original Article Reference

This SciPod is a shortened and simplified summary of ‘Fast Facts: Multiple Sclerosis’ published by Karger Publishers: ISBN 978-1-910797-23-5

The complete original works are available at www.karger.com

Short on time? watch this 3 minute video

About this episode

Multiple sclerosis (MS) is a progressive disease of the nervous system resulting from the inflammation and degeneration of nerves. In developed countries, MS is the primary cause of neurological disability in young and middle-aged people. Worldwide, MS affects an estimated 2.3 million. The cause is unknown and although factors that may increase risk have been identified, attempts to curb disease progression have so far met with failure. However, we are at a turning point in scientific advancement with the emergence of promising new therapies that could help us shift the odds in our favor against this devastating disease.

Related episodes

Prof. Elizabeth Regan | The Healthcare Revolution That Technology Alone Cannot Deliver

Prof. Elizabeth Regan | The Healthcare Revolution That Technology Alone Cannot Deliver

Imagine a patient with several health problems moving through a modern medical system. She may see a family doctor, a specialist, a hospital team, a pharmacist and perhaps a community service. Each professional may be highly skilled. Each organisation may own sophisticated software. Yet the patient can still find herself repeating the same story, carrying information between appointments, waiting for records to arrive and trying to understand who is responsible for what. The individual parts work well, but the journey doesn’t.

Dr Sarah Davies – Dr Clare French | The Vaccine Uptake Recipe: Which Ingredients Work for Different Groups?

Dr Sarah Davies – Dr Clare French | The Vaccine Uptake Recipe: Which Ingredients Work for Different Groups?

Vaccines can prevent serious illness, disability and death, but their benefits depend on people actually receiving them. When vaccination rates fall, the usual question is how to support more people to get vaccinated. Yet that question may be too simple. A reminder, a conversation, a financial incentive or a more convenient clinic can all help, but they do not necessarily help everyone in the same way. That is the central insight emerging from a major analysis led by Dr Sarah Davies and Dr Clare French, both of the University of Bristol, and colleagues. To go beyond asking whether broad categories such as “education” or “improved access” work, the researchers took apart vaccine uptake interventions to examine their individual ingredients. It is a little like studying recipes: knowing that a cake tastes good is useful, but knowing which ingredients make the difference is far more helpful if you want to create a better cake.

Prof. Toine Pieters | The Depression Spiral: Rethinking an Illness That Refuses to Stand Still

Prof. Toine Pieters | The Depression Spiral: Rethinking an Illness That Refuses to Stand Still

What if depression is best understood as a process that gathers momentum, rather than a fixed illness that simply appears once enough symptoms have accumulated? A difficult week becomes persistent stress. Persistent stress demands more coping. Coping becomes exhausting. Sleep, appetite, activity and relationships begin to change. Those changes can then create fresh stress, pushing a person further down a self-reinforcing spiral.

Dr. Linda Mermelstein | When Knowledge Is Not Enough: Building Trust Around Prostate Cancer

Dr. Linda Mermelstein | When Knowledge Is Not Enough: Building Trust Around Prostate Cancer

For many men, a conversation about prostate cancer begins long before they enter a doctor’s office. It may begin when a brother mentions a test, when a friend describes a frightening diagnosis, or when a family member dies from cancer. For Black men, those conversations carry particular urgency. Prostate cancer affects them much more often, yet knowing that a disease is dangerous does not automatically mean people have the information, confidence, or trusted relationships needed to make decisions about screening.

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.